Journal
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Volume 24, Issue 18, Pages 4515-4519Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2014.07.075
Keywords
Vitamin D; Nuclear receptor; Carborane; Non-secosteroid
Categories
Funding
- JSPS KAKENHI [25460146]
- Grants-in-Aid for Scientific Research [24590005, 22136013, 24590137, 25460146] Funding Source: KAKEN
Ask authors/readers for more resources
Vitamin D receptor (VDR), a nuclear receptor for 1 alpha,25-dihydroxyvitamin D-3 (1 alpha,25(OH)(2)D-3, 1), is a promising target for multiple clinical applications. We recently developed non-secosteroidal VDR ligands based on a carbon-containing boron cluster, 1,12-dicarba-closo-dodecaborane (p-carborane), and examined the binding of one of them to VDR by means of crystallographic analysis. Here, we utilized that X-ray structure to design novel p-carborane-based tetraol-type vitamin D analogs, and we examined the biological activities of the synthesized compounds. Structure-activity relationship study revealed that introduction of an omega-hydroxyalkoxy functionality enhanced the biological activity, and the configuration of the substituent significantly influenced the potency. Among the synthesized compounds, 4-hydroxybutoxy derivative 9a exhibited the most potent activity, which was equal to that of the secosteroidal vitamin D analog, 19-nor-1 alpha,25-dihydroxyvitamin D-3 (2). (C) 2014 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available